809 related articles for article (PubMed ID: 22261670)
1. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M
Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
Seet RC; Rabinstein AA
Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
[TBL] [Abstract][Full Text] [Related]
3. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
5. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
Sobesky J; Frackowiak M; Zaro Weber O; Hahn M; Möller-Hartmann W; Rudolf J; Neveling M; Grond M; Schmulling S; Jacobs A; Heiss WD
Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545
[TBL] [Abstract][Full Text] [Related]
6. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
7. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
[TBL] [Abstract][Full Text] [Related]
8. The Belgian experience with intravenous thrombolysis for acute ischemic stroke.
Vanacker P; Thijs V; Peeters A; Bruneel B; Laloux P; Druwé P; De Deyn P; Ahmed N; Wahlgren N; Vanhooren G;
Acta Neurol Belg; 2010 Jun; 110(2):157-62. PubMed ID: 20873445
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
Kellert L; Sykora M; Gumbinger C; Herrmann O; Ringleb PA
Cerebrovasc Dis; 2012; 33(2):135-40. PubMed ID: 22179586
[TBL] [Abstract][Full Text] [Related]
10. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
11. Outcome of intravenous thrombolysis in stroke patients weighing over 100 kg.
Sarikaya H; Arnold M; Engelter ST; Lyrer PA; Mattle HP; Michel P; Odier C; Weder B; Siebel P; Mueller F; Ballinari P; Georgiadis D; Baumgartner RW
Cerebrovasc Dis; 2011; 32(3):201-6. PubMed ID: 21822011
[TBL] [Abstract][Full Text] [Related]
12. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
[TBL] [Abstract][Full Text] [Related]
13. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
14. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
15. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features.
Guillan M; Alonso-Canovas A; Gonzalez-Valcarcel J; Garcia Barragan N; Garcia Caldentey J; Hernandez-Medrano I; Defelipe-Mimbrera A; Sanchez-Gonzalez V; Terecoasa E; Alonso de Leciñana M; Masjuan J
Cerebrovasc Dis; 2012; 34(2):115-20. PubMed ID: 22854315
[TBL] [Abstract][Full Text] [Related]
16. Safety and outcome after thrombolysis in stroke patients with mild symptoms.
Köhrmann M; Nowe T; Huttner HB; Engelhorn T; Struffert T; Kollmar R; Saake M; Doerfler A; Schwab S; Schellinger PD
Cerebrovasc Dis; 2009; 27(2):160-6. PubMed ID: 19092237
[TBL] [Abstract][Full Text] [Related]
17. Thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack.
Alonso de Leciñana M; Fuentes B; Masjuan J; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Egido JA
Int J Stroke; 2012 Apr; 7(3):213-8. PubMed ID: 22098785
[TBL] [Abstract][Full Text] [Related]
18. Impact of statin use and lipid profile on symptomatic intracerebral haemorrhage, outcome and mortality after intravenous thrombolysis in acute stroke.
Rocco A; Sykora M; Ringleb P; Diedler J
Cerebrovasc Dis; 2012; 33(4):362-8. PubMed ID: 22433177
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).
Mori E; Minematsu K; Nakagawara J; Yamaguchi T;
J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):517-22. PubMed ID: 20719535
[TBL] [Abstract][Full Text] [Related]
20. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.
Miyagi T; Koga M; Shiokawa Y; Nakagawara J; Hasegawa Y; Furui E; Kimura K; Kario K; Okuda S; Yamagami H; Okada Y; Nezu T; Maeda K; Endo K; Minematsu K; Toyoda K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
